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Abstract
Joint hemorrhages are very common in patients with severe
hemophilia. Inhibitors in patients with hemophilia are allo-anti-
bodies that neutralize the activity of the clotting factor. After total
knee replacement, rare intra-articular bleeding complications might
occur that do not respond to clotting factor replacement. We report
a 40-year-old male with severe hemophilia A and high responding
inhibitors presenting with recurrent knee joint hemorrhage after
bilateral knee prosthetic surgery despite adequate clotting factor
treatment. There were two episodes of marked postoperative
hemarthrosis requiring extensive use of subsititution therapy.
Eleven days postoperatively, there was further hemorrhage into the
right knee. Digital subtraction angiography diagnosed a compli-
cating pseudoaneurysm of the inferior lateral geniculate artery and
embolization was successfully performed. Because clotting factor
replacement therapy has proved to be excessively expensive and
prolonged, especially in patients with inhibitors, we recommend
the use of cost-effective early angiographic embolization.
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Arterial bleeding as an exceptional complication following total
knee arthroplasty (TKA) is an extremely rare entity in general, with
an incidence of approximately 0.03% [1–3]. Pathologically, lac-
erations, pseudoaneurysms, and arteriovenous fistula might occur;
most commonly, intrinsic (iatrogenic) as well as extrinsic risk
factors are supposed to be causative for these bleeding phenomena
[2]. In this context, hemophilia with high inhibitor titers is an
essential predisposing factor for the acute onset of profuse life- or
limb-threatening hemorrhage, especially in the postoperative
phase [4–9]. High-dose clotting factor replacement therapy is the
first-line treatment in hemophilic patients with inhibitors and
postoperative episodes of bleeding [10, 11]. High costs, occasional
ineffectiveness in patients with inhibitors, and thrombembolic
complications are potential disadvantages of this therapy [12].
Surgical treatment is an option in hemophiliacs with active
bleeding after arthroplasty [7, 8]. Nevertheless, there are situations
in which a surgical approach might be catastrophic—for example,
failure of surgical attempts to stop bleeding, the inability to
maintain satisfactory hematocrit levels, developing coagulation
problems despite adequate substitution, or provocation of
infections [13].
The role of transcatheter arterial embolization (TAE) in the
therapy of hemophilic pseudoaneurysms in patients with high
inhibitor titers after elective orthopedic surgery (EOS) has, so far,
only been addressed in a few publications [4,11, 14, 15]. This case
therefore highlights the necessity of including this kind of alter-
native therapy in the subsequent management of spontaneous
hemophilic bleeding complications with regard to ineffective
hemostatic cover and to cost reduction.
Case Report
A 40-year old male patient with severe hemophilia A (factor VIII:C <
1%) and high responding inhibitors and with a familial history of
hemophilia presented with extensive knee pain, marked fixed flexion
deformity of approximately 20, and a progressive inability to walk. The
genetic mutation for hemophilia A could not be identified. An intron 22
inversion, which is commonly seen with severe hemophilia A with high
responding inhibitors, was, however, excluded. Since the late 1970s, the
patient has been on home treatment and was seen regularly in the
Hemophilia Center of our hospital. His clotting factor therapy consisted
of factor VIII inhibiting bypassing activity (FEIBA; Baxter AG, Vol-
ketswil, Switzerland), porcine factor VIII (Hyate C; Opopharma AG,
Glattbrugg, Switzerland), and, for the last 2 years, recombinant activated
factor VIIa (rFVIIa; NovoSeven; Novo Nordisk, Bagsvaerd, Denmark).
The patient is human immunodeficiency virus (HIV) negative and has an
associated transfusion hepatitis B and chronic hepatitis C without any
features of liver cirrhosis.
Recurrent joint hemorrhage led to a severe hemophilic arthropathy
involving the knees, elbows, and ankle joints. Persistent hemorrhage and
associated secondary degenerative disease led to a severe bilateral knee
fixed flexion deformity associated with severe pain and progressive diffi-
culty in walking. The patient was hardly able to rise from a seated position.
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inhibitors and in order to restrain costs, bilateral knee replacement surgery
at one setting was recommended.
At hospitalization, 4 days preoperatively, the inhibitor level was low
with 2 Bethesda units (BU). After a dose of rFVIIa (120 lg/kg body weight),
a central venous catheter was inserted for the delivery of extracorporeal
Protein-A immunoadsorption (PAIA) treatment. PAIA was administered on
day 3 and day 1 before surgery and three times postoperatively. Unfortu-
nately, there was extensive complicating soft tissue hemorrhage around the
catheter site and 10 additional doses of rFVIIa were necessary.
Prior to surgery, the inhibitor titer was not detectable. Factor VIII [a
total dose of 10,000 IU (i.e. 100 IU/kg body weight) Haemate HS; ZLB
Behring AG, Berne, Switzerland) was administered immediately before and
during surgery. The factor VIII:C level was brought to 124% and kept
above 100% during surgery and the first 3 postoperative days. TKAs were
performed bilaterally under tourniquet control to minimize bleeding at the
bone-cement interface. The operation was performed by an anteromedial
approach without osteotomy of the tuberosities. In order to mobilize the
knees, an extensive adhesiolysis of the dorsal capsule and the collateral
ligaments had to be performed. Both components (femoral and tibial) were
cemented with an ultracongruent tibial polyethylene plateau (Innex;
Sulzer AG, Baar, Switzerland), sacrifying the posterior cruciate ligament.
At the end of surgery, the right knee joint had a flexion to 80 and an
extension deficit of 5 and the left knee had a flexion to 80 with full
extension. Operative time was 1.5 h per knee joint and there were no
complications reported during surgery.
Postoperatively, thrombosis prophylaxis with subcutaneous LMW
Heparin was administered for the period of time of factor VIII replacement.
On day 4 postoperatively, the inhibitor titer increased and the response to
substitution with factor VIII decreased. On the fifth, seventh, and eighth
postoperative day, PAIA was administered again in an attempt to reduce the
rising inhibitor titer, but without success. The treatment was changed to
rFVIIa (120 lg/kg every 3 h). Despite this aggressive regimen, bleeding
into the right knee joint was observed, and on the sixth postoperative day,
hemorrhage of the left knee joint was additionally diagnosed. After
increasing the therapy with rFVIIa, the hemorrhages stopped. On the 11th
postoperative day, the patient complained of new and severe pain within the
right knee. Color duplex flow ultrasound (US) suggested the diagnosis of a
pseudoaneurysm.
With the patient under local anesthesia, digital subtraction angiography
(DSA) via a femoral artery approach was performed using a 5F vascular
sheath (Terumo, Tokyo, Japan). A 5F pigtail catheter (Cook, Bloomington,
IN, USA) was used to obtain a nonselective diagnostic arteriogram to
identify the source of the bleeding. Selective angiography was performed
with a cobra-shaped catheter (5F, C-2; Cook, Bloomington, IN, USA) in
order to localize the feeding artery. Diagnostic catheter maneuvers were
usually done using a steerable 0.035-in. guidewire (Radifocus; Terumo,
Tokyo, Japan). DSA confirmed the suspected diagnosis of a pseudoaneu-
rysm arising from the inferior lateral geniculate artery (Fig. 1). TAE was
then performed using a coaxially placed microcatheter (Progreat; Terumo,
Tokyo, Japan) in proximity to the bleeding branch. For TAE, five fibered
0.018-in. platinum microcoils (VortX; Boston Scientific, Natick, MA,
USA) with a nominal configured diameter of 2 · 3 mm to 2 · 4 mm and a
stretched length of 22–30 mm were used. Coil detachment was performed
by saline injection. Using TAE, bleeding was effectively stopped within 15
min. At the end of the procedure, a closure device (AngioSeal; St. Jude
Medical Devices, Minneapolis, MN, USA) was used to allow safe closure
of the puncture site.
As a result of TAE, rapid mobilization of the patient with crutches was
possible and he was discharged on day 26. Three months postoperatively at
clinical follow-up there was bilateral flexion to 90 passively and to 80
actively. There was a 5 extension deficit bilaterally. Rebleeding did not
occur. The patient is now able to walk continuously and unassisted for up to
3 h; in addition, there is less pressure and pain associated with his ankle
joints bilaterally. All in all, factor replacement therapy was performed by
supplementation of 59,000 IU of factor VIII and 1464 mg of rFVIIa, with
carrying costs of approximately 750000 e.
Discussion
Bleeding into a ‘‘target‘‘ joint like the knee is most commonly
observed in patients with hemophilia A and is usually due to sy-
novialitis, erosion, joint destruction, debilitating pain, and sec-
ondary osteoarthritis, in addition to the primary disorder [4, 11,
15]. Rarely have pseudoaneurysms of the arteries supplying the
knee joint been described in association with end-stage hemophilic
arthropathy as the cause of hemarthrosis [4, 15]. With the avail-
ability of adequate clotting factor concentrates, elective TKA has
developed to a well-accepted and widespread approach in hemo-
philiacs, even in those with inhibitors [5–8, 11, 16, 17]. TKA in
hemophilia A has been shown to reduce pain and to be associated
with a general decreased tendency for hemarthrosis and an
undisputed improvement in the quality of life with better mobility
[6, 11, 17]; however, perioperatively and postoperatively, some
evident complications might occur. The most commonly reported
complication of total knee replacement in the setting of hemophilic
arthropathy is that of early and late infection and late loosening of
the prosthesis, the latter two of which have been described as
occurring at a higher rate in patients who are seropositive for HIV
[17, 18]. Legroux-Gerot et al. [18] described recurrent hemar-
throsis after TKA in 6 of 12 patients with 17 total knee prostheses,
with some requiring synovectomy for recurrent hemorrhage.
Thomason et al. [5] reported early perioperative knee joint hem-
orrhage in 3 of 23 TKAs; however, the cause and treatment was not
stated.
Arterial injury in terms of exravasations, pseudoaneurysms, and
arteriovenous fistulas during or after TKA might account for a
minority of limb- or life-threatening complications, with a latency
usually ranging from hours to years [2, 3]. Etiologically, there
seems to be an intrinsic risk of developing these vascular com-
plications due to the close proximity of significant vascular
structures and the area of operative manipulation. In this context,
vascular laceration or avulsion by inappropriately placed retractors,
overextension, or direct penetration from gouging are, by far, the
most common mechanisms of arterial damage [1, 3]. Aside from
hemophilia, other extrinsic risk factors appear to also play an
important role in the development of serious vascular injury after
TKA [1, 2, 11]. Many authors stressed the fact that peripheral
vascular disease (PVD) is a predominant factor for such a com-
plication [2]. Other investigators reported that foreign body
infection, prosthetic loosening, intrapelvic migration, the intense
heat of polymerization from methyl methacrylate, or repeated
trauma by osteophytes, and screw as well as cement erosion were
further extrinsic reasons for the occurrence of serious arterial in-
jury [1]. In our patient, it remains speculative if the pseudoaneu-
rysm of the right inferior lateral geniculate artery already existed
prior to TKA, because angiographic diagnosis had only been made
postoperatively. However, regarding the postoperative follow-up, it
is most likely that the pseudoaneurysm of the right inferior lateral
geniculate artery had been caused iatrogenically.
Generally, pseudoaneurysm formation complicating TKA in
hemophilic arthropathy is rare, with approximately a handful of
cases being reported in the world literature [4, 11, 15]. Associated
features include a cavity filled with hematoma and surrounded by
adventitia, perivascular tissue, and fibrotic tissue deriving from the
hematoma [9, 14, 15].
The definitive strategy for bleeding episodes complicating TKA
in hemophilic arthropathy is replacement therapy with clotting
factors [10, 11]. However, bleeding complications in severely
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damaged joints or after elective orthopedic surgery are sometimes
unresponsive to this kind of treatment, particularly in hemophilia
patients with inhibitors [12]. In such situations, an alternative op-
tion, especially for the therapy of pseudoaneurysms, is a surgical
approach [2, 7, 8]. Surgical treatment usually includes ligation,
simple resection of the pseudoaneurysm, closing of the defect with
a patch, bypass grafting, end-to-end anastomoses, endan-
eurysmorrhaphy, and open synovectomy [1, 2, 7]. However, it is
important to realize that an open surgical procedure might fail, as
the source of bleeding is not always apparent [1, 2]. Another po-
tential disadvantage of open surgery is that dissection is required in
an inflamed area [2]. In addition, surgical interventions might be
complicated by deep infection or anatomic distortion from the
pseudoaneurysm, or patients might have an increased risk of re-
gional or general anesthetic episodes [13].
With the advent of newer coaxial microcatheter systems and the
improvement of embolization techniques, there is an increasing
interest in catheter-based treatment as an alternative therapeutic
strategy for pseudoaneurysms after TKA, also in hemophiliacs [4,
11, 15, 19, 20]. It is important to note that with respect to coaxial
embolization, acute curving of the microcatheter does not present
an obstacle, even for the delivery of microcoils into second- or
third-order vessel locations [1, 11, 15]. Some investigators pointed
out that percutaneous TAE, carried out as selectively as possible,
might improve the chances of success and reduce the risk of
complications such as ischemia, as it seems to be less invasive in
comparison with a surgical approach [2, 11, 19, 20]. Another
advantage of a coaxial technique with microcatheter and microcoil
systems is that it allows precise localization and catheterization of
the bleeding arterial branches [11]. Moreover, this case and the
small series from Saris et al. [4] suggest that interventional angi-
ography might have a role when there is clinical concern for a
pseudoaneurysm, allowing for contemporaneous diagnosis and
therapy. Nevertheless, this procedure at least requires clotting
factor replacement therapy for the groin puncture.
Arthroplasty in hemophilic arthropathy is known to be costly,
with a mean of 105885 e and a range from 56311 e to 174907 e
[18, 21]; the mean estimated costs are 7045 e for surgery, 2345 e
for the prosthesis, 93392 e for clotting factors, and 3174 e for
rehabilitation. In general, clotting factor replacement might con-
tribute to 88% of the total cost [18]. However, as seen in our case,
the costs for clotting factors might dramatically increase if
hemarthrosis occurs postoperatively or during rehabilitation,
especially in patients with inhibitors.
In conclusion, because of a complicating pseudoaneurysm of
the inferior lateral geniculate artery with hemarthrosis after TKA,
Fig. 1. (A) Selective angiogram obtained in a left
oblique projection demonstrates a large
pseudoaneurysm of the right inferior lateral
geniculate artery (arrow). (B) Superselective
angiogram obtained in a left oblique projection by
using a 3F microcatheter confirms diagnosis of a
solitary pseudoaneurysm of the left inferior lateral
geniculate artery (arrow). (C) Selective angiogram
obtained in a left oblique projection after the
successful embolization with microcoils (arrow).
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our patient had to be treated for a longer period of time and at a
more intensive level, which proved to be extremely costly. He
suffered an extended period of pain and his rehabilitation was
markedly prolonged from a usual 2-month period to 3 months,
with nearly 4 weeks of hospitalization. Initially, hemarthrosis
after TKA was thought to be caused by the patient`s primary
disorder and was, therefore, treated by clotting factors. After
clotting factor replacement therapy had failed, an alternative
diagnosis was thought to be causative for excessive bleeding and
severe pain. Angiography with embolization represented a mini-
mally invasive interventional technique to efficiently diagnose
and treat the pseudoaneurysm formation. Radiologists as well as
clinicians should be aware of this cost-effective modality that
requires close therapeutic alliance in order to advance the stan-
dard of care for hemophiliacs. In this context, they should also
keep in mind that pseudoaneurysms are extremely infrequent
conditions that might not only occur after TKA but also without
previous surgery in hemophilia patients; for that reason, preop-
erative angiography is recommended in these special patients. On
the basis of these facts, this case illustrates that a timely intra-
disciplinary approach to diagnosis and treatment is of utmost
importance and that there is a need for regular conjoint confer-
ences and meetings.
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